Erianin Inhibits Proliferation and Induces Apoptosis of HaCaT Cells Via ROS-Mediated JNK/c-Jun and AKT/mTOR Signaling Pathways

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2019 Jul 31

PMID 31357564

Citations 15

Authors

Canlong Mo

Dattatrya Shetti

Kun Wei

Affiliations

Soon will be listed here.

Abstract

Psoriasis is a recurrent skin disease described as keratinocyte hyperproliferation and aberrant differentiation. Erianin, a bibenzyl compound extracted from , has displayed antitumor and anti-angiogenesis effects. However, the effects of erianin on a human keratinocyte cell line (HaCaT) are not fully understood. In the present study, we explored the effect of erianin on proliferation and apoptosis in HaCaT cells. Our results indicated that treatment with erianin ranging from 12.5 nM to 50 nM inhibited proliferation and induced apoptosis of HaCaT cells. In addition, erianin-induced apoptosis was accompanied by elevated reactive oxygen species (ROS). The ROS scavenger -acetyl-cysteine (NAC) attenuated this elevation. Moreover, treatment with erianin induced activation of the c-Jun N-terminal kinase (JNK)/c-Jun signaling pathway and suppressed the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway, while pretreatment with NAC also reversed these effects. Collectively, these data demonstrated that erianin inhibited proliferation and induced apoptosis of HaCaT cells through ROS-mediated JNK/c-Jun and AKT/mTOR signaling pathways. Erianin could be recognized as a potential anti-psoriasis drug.

Citing Articles

Mechanistic study of Erianin in alopecia areata.

Xuan X, Zhang G, Zhang J, Zhu Q, Zhang Y, Liu L Am J Transl Res. 2025; 17(1):550-559.

PMID: 39959223 PMC: 11826198. DOI: 10.62347/DHJM6411.

Erianin inhibits the progression of DDP-resistant lung adenocarcinoma by regulating the Wnt/β-catenin pathway and activating the caspase-3 for apoptosis in vitro and in vivo.

Tang L, Ruan Y, Wang B, Zhang M, Xue J, Wang T Hereditas. 2024; 161(1):48.

PMID: 39605083 PMC: 11600767. DOI: 10.1186/s41065-024-00351-x.

Biochanin A Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Modulating the NF-κB and MAPK Signaling Pathways.

Walvekar K, Tirunavalli S, Eedara A, Chandra Y, Kuncha M, B R Kumar A Inflammation. 2024; .

PMID: 39017810 DOI: 10.1007/s10753-024-02103-5.

Erianin promotes apoptosis and inhibits Akt-mediated aerobic glycolysis of cancer cells.

Han S, Chen S, Wang J, Huang S, Xiao Y, Deng G J Cancer. 2024; 15(8):2380-2390.

PMID: 38495480 PMC: 10937289. DOI: 10.7150/jca.92780.

Erianin: A phytoestrogen with therapeutic potential.

Li G, Zhang H, Lai H, Liang G, Huang J, Zhao F Front Pharmacol. 2023; 14:1197056.

PMID: 37608888 PMC: 10440559. DOI: 10.3389/fphar.2023.1197056.

References

Peus D, Beyerle A, Rittner H, Pott M, Meves A, Weyand C . Anti-psoriatic drug anthralin activates JNK via lipid peroxidation: mononuclear cells are more sensitive than keratinocytes. J Invest Dermatol. 2000; 114(4):688-92. DOI: 10.1046/j.1523-1747.2000.00934.x. View

Takahashi H, Ibe M, Nakamura S, Ishida-Yamamoto A, Hashimoto Y, Iizuka H . Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis. J Dermatol Sci. 2002; 30(2):94-9. DOI: 10.1016/s0923-1811(02)00064-6. View

Gong Y, Fan Y, Wu D, Yang H, Hu Z, Wang Z . In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agent. Eur J Cancer. 2004; 40(10):1554-65. DOI: 10.1016/j.ejca.2004.01.041. View

Lluis J, Buricchi F, Chiarugi P, Morales A, Fernandez-Checa J . Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. Cancer Res. 2007; 67(15):7368-77. DOI: 10.1158/0008-5472.CAN-07-0515. View

Roy P, Rashid F, Bragg J, Ibdah J . Role of the JNK signal transduction pathway in inflammatory bowel disease. World J Gastroenterol. 2008; 14(2):200-2. PMC: 2675114. DOI: 10.3748/wjg.14.200. View

Zhou Q, Mrowietz U, Rostami-Yazdi M . Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med. 2009; 47(7):891-905. DOI: 10.1016/j.freeradbiomed.2009.06.033. View

Zimmermann M, Koreck A, Meyer N, Basinski T, Meiler F, Simone B . TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis. J Allergy Clin Immunol. 2011; 127(1):200-7, 207.e1-10. DOI: 10.1016/j.jaci.2010.11.005. View

Shen S, Lee W, Yang L, Tsai H, Yang L, Chen Y . Quercetin enhancement of arsenic-induced apoptosis via stimulating ROS-dependent p53 protein ubiquitination in human HaCaT keratinocytes. Exp Dermatol. 2012; 21(5):370-5. DOI: 10.1111/j.1600-0625.2012.01479.x. View

Seki E, Brenner D, Karin M . A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology. 2012; 143(2):307-20. PMC: 3523093. DOI: 10.1053/j.gastro.2012.06.004. View

10.

Bito T, Nishigori C . Impact of reactive oxygen species on keratinocyte signaling pathways. J Dermatol Sci. 2012; 68(1):3-8. DOI: 10.1016/j.jdermsci.2012.06.006. View

11.

Mitra A, Raychaudhuri S, Abria C, Mitra A, Wright R, Ray R . 1α,25-Dihydroxyvitamin-D3-3-bromoacetate regulates AKT/mTOR signaling cascades: a therapeutic agent for psoriasis. J Invest Dermatol. 2013; 133(6):1556-64. DOI: 10.1038/jid.2013.3. View

12.

Cho H, Park S, Heo K, Hur D . Methotrexate induces apoptosis in nasal polyps via caspase cascades and both mitochondria-mediated and p38 mitogen-activated protein kinases/Jun N-terminal kinase pathways. Am J Rhinol Allergy. 2013; 27(1):e26-31. DOI: 10.2500/ajra.2013.27.3849. View

13.

George S, Anderson R, Haswell M, Groundwater P . An investigation of the effects of dithranol-induced apoptosis in a human keratinocyte cell line. J Pharm Pharmacol. 2013; 65(4):552-60. DOI: 10.1111/jphp.12019. View

14.

Wagener F, Carels C, Lundvig D . Targeting the redox balance in inflammatory skin conditions. Int J Mol Sci. 2013; 14(5):9126-67. PMC: 3676777. DOI: 10.3390/ijms14059126. View

15.

Datta-Mitra A, Mitra A, Ray R, Raychaudhuri S, Kundu-Raychaudhuri S . 1,25-Dihydroxyvitamin D3-3-bromoacetate, a novel vitamin D analog induces immunosuppression through PI3K/Akt/mTOR signaling cascade. Int Immunopharmacol. 2013; 17(3):744-51. DOI: 10.1016/j.intimp.2013.08.009. View

16.

Huang T, Lin X, Meng X, Lin M . Phosphoinositide-3 kinase/protein kinase-B/mammalian target of rapamycin pathway in psoriasis pathogenesis. A potential therapeutic target?. Acta Derm Venereol. 2013; 94(4):371-9. DOI: 10.2340/00015555-1737. View

17.

Saraswati S, Kumar S, Alhaider A . α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway. Mol Cancer. 2013; 12:147. PMC: 4221991. DOI: 10.1186/1476-4598-12-147. View

18.

Janjetovic Z, Nahmias Z, Hanna S, Jarrett S, Kim T, Reiter R . Melatonin and its metabolites ameliorate ultraviolet B-induced damage in human epidermal keratinocytes. J Pineal Res. 2014; 57(1):90-102. PMC: 4106994. DOI: 10.1111/jpi.12146. View

19.

Boehncke W, Schon M . Psoriasis. Lancet. 2015; 386(9997):983-94. DOI: 10.1016/S0140-6736(14)61909-7. View

20.

Holmdahl R, Sareila O, Olsson L, Backdahl L, Wing K . Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation. Immunol Rev. 2015; 269(1):228-47. DOI: 10.1111/imr.12378. View